Prevalence of anti-varicella-zoster virus antibodies in french Infants under 15 months of age

Clinical and Vaccine Immunology

Volumn 16, Issue 4, 2009, Pages 484-487

  Pinquier, Didier ^a   Gagneur, Arnaud ^b   Balu, Laurent ^c   Brissaud, Olivier ^d   Guen, Christèle Gras Le ^e   Hau Rainsard, Isabelle ^f   Mory, Olivier ^g   Picherot, Georges ^e   De Pontual, Loïc ^c   Jean Louis, Stephan ^g   Maple, Peter ^l   Breuer, Judith ^k   Aubert, Marie ^m   Caulin, Evelyne ^m   Sana, Claudine ^m   Pradat, Pierre ^i,k,l   Soubeyrand, Benoît ^j   Reinert, Philippe ^h  

^a HÔPITAL CHARLES NICOLLE   (France)

^b BREST UNIVERSITY HOSPITAL   (France)

^c Hôpita Jean Verdier   (France)

^d BORDEAUX UNIVERSITY HOSPITAL   (France)

^e Hopital Mere Enfant CHU de Nantes   (France)

^f CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^g HÔPITAL NORD   (France)

^h SANOFI PASTEUR   (France)

ⁱ HOSPICES CIVILS DE LYON   (France)

^j UNIVERSITÉ LYON 1   (France)

^k INSERM   (France)

^l PUBLIC HEALTH ENGLAND   (United Kingdom)

^m QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MATERNAL ANTIBODY;

ANTIBODY TITER; ARTICLE; CHICKENPOX; FRANCE; HALF LIFE TIME; HUMAN; IMMUNIZATION; IMMUNOASSAY; INFANT; MATERNAL DISEASE; NORMAL HUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; VARICELLA ZOSTER VIRUS;

EID: 64549130835     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00397-08     Document Type: Article

References (23)

1. Asano, Y., Y. Hiroishi, N. Itakura, S. Hirose, Y. Kajita, S. Suga, and T. Yazaki. 1988. Placental transfer of IgG subclass-specific antibodies to varicella-zoster virus. J. Med. Virol. 26:1-6.
2. 1a.Asano, Y., and M. Takahashi. 1978. Studies on neutralization of varicellazoster virus and serological follow-up of cases of varicella and zoster. Biken J. 21:15-23.
3. Bonmarin, I., B. Ndiaye, E. Seringe, and D. Levy-Bruhl. 2005. Épidémiologie de la varicelle en France. Bull. Épidémiol. Hebdom. 8:30-31.
4. Coudeville, L., A. Brunot, T. D. Szucs, and B. Dervaux. 2005. The economic value of childhood varicella vaccination in France and Germany. Value Health 8:209-222.
5. Coudeville, L., F. Paree, T. Lebrun, and J. Sailly. 1999. The value of varicella vaccination in healthy children: cost-benefit analysis of the situation in France. Vaccine 17:142-151.
6. Evans, H. E., S. O. Akpata, and L. Glass. 1971. Serumimmunoglobulinlevels in premature and full-term infants. Am. J. Clin. Pathol. 56:416-418.
7. Galil, K., C. Brown, F. Lin, and J. Seward. 2002. Hospitalizations for varicella in the United States, 1988 to 1999. Pediatr. Infect. Dis. J. 21:931-935.
8. Gershon, A. A., R. Raker, S. Steinberg, B. Topf-Olstein, and L. M. Drusin. 1976. Antibody to varicella-zoster virus in parturient women and their offspring during the first year of life. Pediatrics 58:692-696.
9. Grimprel, E., C. Levy, F. de La Rocque, R. Cohen, B. Soubeyrand, E. Caulin, T. Derrough, A. Lecuyer, P. d'Athis, and J. Gaudelus. 2007. Paediatric varicella hospitalisations in France: a nationwide survey. Clin. Microbiol. Infect. 13:546-549.
10. Haut Conseil de la Santé Publique. 22 April 2008. Vaccination schedule for 2008. Recommendations from the Haut Conseil de la Santé Publique. Bull. Épidémiol. Hebdom. 16-17:129-148. (In French.)
11. Heininger, U., D. Desgrandchamps, and U. B. Schaad. 2006. Seroprevalence of varicella-zoster virus IgG antibodies in Swiss children during the first 16 months of age. Vaccine 24:3258-3260.
12. Khoshnood, B., M. Debruyne, F. Lancon, C. Emery, F. Fagnani, I. Durand, and D. Floret. 2006. Seroprevalence of varicella in the French population. Pediatr. Infect. Dis. J. 25:41-44.
13. Leineweber, B., V. Grote, U. B. Schaad, and U. Heininger. 2004. Transplacentally acquired immunoglobulin G antibodies against measles, mumps, rubella and varicella-zoster virus in preterm and full term newborns. Pediatr. Infect. Dis. J. 23:361-363.
14. Linder, N., L. Sirota, Y. Aboudy, B. German, T. Lifshits, B. S. Barnea, B. Lieberman, E. Mendelson, and A. Barzilai. 1999. Placental transfer of maternal rubella antibodies to full-term and preterm infants. Infection 27:203-207.
15. Linder, N., I. Waintraub, Z. Smetana, A. Barzilai, D. Lubin, E. Mendelson, and L. Sirota. 2000. Placental transfer and decay of varicella-zoster virus antibodies in preterm infants. J. Pediatr. 137:85-89.
16. Maple, P. A., J. J. Gray, K. Brown, and D. W. Brown. 2009. Performance characteristics of a quantitative, standardised varicella-zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring immunity following natural infection. J. Virol. Methods 157:90-92.
17. Maple, P. A. C., J. Gray, J. Breuer, G. Kafatos, S. Parker, and D. Brown. 2006. Performance of a time-resolved fluorescence immunoassay for measuring varicella-zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassay. Clin. Vaccine Immunol. 13:214-218.
18. Meyer, P. A., J. F. Seward, A. O. Jumaan, and M. Wharton. 2000. Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. J. Infect. Dis. 182:383-390.
19. Mirlesse, V., J. F. Magny, Y. Sole, F. Jacquemard, F. Forestier, and F. Daffos. 1998. VZV infection concerning pregnant women and new-borns. Med. Mal. Infect. 28:782-790.
20. Ozaki, T., H. Nagai, T. Kimura, T. Ichikawa, S. Suzuki, H. Kito, and Y. Asano. 1980. The age distribution of neutralizing antibodies against varicella-zoster virus in healthy individuals. Biken J. 23:9-14.
21. Saadatian-Elahi, M., Y. Mekki, C. Del Signore, B. Lina, T. Derrough, E. Caulin, J. Thierry, and P. Vanhems. 2007. Seroprevalence ofvaricella antibodies among pregnant women in Lyon-France. Eur. J. Epidemiol. 22:405-409.
22. Sarvas, H., I. Seppala, S. Kurikka, R. Siegberg, and O. Makela 1993. Half-life of the maternal IgG1 allotype in infants. J. Clin. Immunol. 13:145-151.
23. van der Zwet, W. C., C. M. Vandenbroucke-Grauls, R. M. van Elburg, A. Cranendonk, and H. L. Zaaijer. 2002. Neonatal antibody titers against varicella-zoster virus in relation to gestational age, birth weight, and maternal titer. Pediatrics 109:79-85.